HIV eradication: Is cord blood the answer?

The Lancet HIV

Volumn 2, Issue 6, 2015, Pages e219-e220

  Henrich, Timothy J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PRIORITY JOURNAL; REMISSION; UMBILICAL CORD BLOOD; VIREMIA; VIRUS LOAD; CORD BLOOD STEM CELL TRANSPLANTATION; FETUS BLOOD; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; MALE; TRANSPLANTATION;

CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HUMANS; MALE; RECEPTORS, CCR5;

EID: 84946712884     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(15)00088-0     Document Type: Note

References (12)

1. Allers K, Hutter G, Hofmann J, et al. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. Blood 2011; 117: 2791-99.
2. Hutter G, Nowak D, Mossner M, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009; 360: 692-98.
3. Avettand-Fenoel V, Mahlaoui N, Chaix ML, et al. Failure of bone marrow transplantation to eradicate HIV reservoir despite effi cient HAART. AIDS 2007; 21: 776-77.
4. Serrano D, Miralles P, Balsalobre P, et al. Graft-versus-tumor eff ect after allogeneic stem cell transplantation in HIV-positive patients with high-risk hematologic malignancies. AIDS Res Hum Retroviruses 2013; 29: 1340-45.
5. Woolfrey AE, Malhotra U, Harrington RD, et al. Generation of HIV-1-specifi c CD8+ cell responses following allogeneic hematopoietic cell transplantation. Blood 2008; 112: 3484-87.
6. Henrich TJ, Hanhauser E, Marty FM, et al. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann Intern Med 2014; 161: 319-27.
7. Henrich TJ, Hu Z, Li JZ, et al. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis 2013; 207: 1694-702.
8. Kuball J, Kwon M, Wensing A, et al. Single cord blood transplantation combined with an HLA mismatched third party donor for high-risk haematological patients and HIV infection. Bone Marrow Transplant 2013; 48: S65-S66.
9. Kordelas L, Verheyen J, Beelen DW, et al. Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation. N Engl J Med 2014; 371: 880-82.
10. Duarte RF, Salgado M, Sánchez-Ortega I, et al. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report. Lancet HIV 2015; published online May 20. http://dx.doi.org/10.1016/ S2352-3018(15)00083-1.
11. Hutter G. More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32/delta32 mutation. N Engl J Med 2014; 371: 2437-38.
12. Duarte RFF, Labopin M, Badoglio M, et al. Allogeneic transplantation in patients with HIV-infection: a pair matched cohort study by the european society for blood and marrow transplantation. Bone Marrow Transplant 2015; 50 (suppl 1): S5-S6.